Ligand validation:6HLP

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 6HLP designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6HLP_OLC_A_1540	19%	32%	0.17	0.87	1.48	1.31	1	1	0	0	40%	0.4
6HLP_OLC_A_1512	14%	49%	0.276	0.86	1.02	0.96	1	1	2	0	80%	0.8
6HLP_OLC_A_1539	13%	42%	0.207	0.809	1.15	1.13	1	1	0	0	68%	0.68
6HLP_OLC_A_1513	10%	52%	0.206	0.728	0.97	0.91	1	1	2	0	92%	0.92
6HLP_OLC_A_1515	7%	45%	0.212	0.726	1.14	1.03	1	1	0	0	68%	0.68
6HLP_OLC_A_1516	2%	43%	0.306	0.646	1.19	1.06	1	2	1	0	60%	0.6
6HLP_OLC_A_1514	1%	45%	0.311	0.557	1.16	0.98	1	1	0	0	68%	0.68
6HLO_OLC_A_1520	9%	42%	0.301	0.859	1.2	1.12	1	2	1	0	60%	0.6
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	62%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	58%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	55%	0.146	0.929	0.68	1.06	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.